{"id":31262,"date":"2026-03-05T10:56:26","date_gmt":"2026-03-05T09:56:26","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=31262"},"modified":"2026-03-05T10:56:28","modified_gmt":"2026-03-05T09:56:28","slug":"lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/","title":{"rendered":"L&#8217;ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l&#8217;Europe face aux maladies infectieuses"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"789\" height=\"237\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png\" alt=\"\" class=\"wp-image-31263\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png 789w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC-300x90.png 300w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC-768x231.png 768w\" sizes=\"(max-width: 789px) 100vw, 789px\" \/><\/figure>\n\n\n\n<p>Le Centre europ\u00e9en de pr\u00e9vention et de contr\u00f4le des maladies (ECDC) recommande la cr\u00e9ation de quatre nouveaux laboratoires de r\u00e9f\u00e9rence de l&#8217;UE (EURL) pour la sant\u00e9 publique. Ces laboratoires sp\u00e9cialis\u00e9s fourniraient un soutien scientifique expert, renforceraient les capacit\u00e9s de diagnostic et contribueraient \u00e0 garantir des donn\u00e9es comparables et de haute qualit\u00e9 dans tous les pays de l&#8217;UE\/EEE pour certaines des maladies infectieuses les plus mena\u00e7antes.<\/p>\n\n\n\n<p>Ces laboratoires, qui deviendraient op\u00e9rationnels en janvier 2028, seraient ax\u00e9s sur : <\/p>\n\n\n\n<ul>\n<li><em><strong>Clostridioides difficile<\/strong><\/em>, l&#8217;un des agents pathog\u00e8nes associ\u00e9s aux soins de sant\u00e9 les plus courants en Europe<\/li>\n\n\n\n<li>La <strong>gonorrh\u00e9e pharmacor\u00e9sistante <\/strong>qui continue de progresser dans l&#8217;UE\/EEE<\/li>\n\n\n\n<li>La <strong>tuberculose<\/strong> qui reste un d\u00e9fi persistant en mati\u00e8re de sant\u00e9 publique, en particulier les formes pharmacor\u00e9sistantes<\/li>\n\n\n\n<li>Les <strong>maladies bact\u00e9riennes invasives<\/strong> telles que la m\u00e9ningite qui provoquent des affections graves et n\u00e9cessitent une identification rapide et pr\u00e9cise des agents pathog\u00e8nes<\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.ecdc.europa.eu\/en\/news-events\/ecdc-proposes-new-eu-reference-laboratories-strengthen-europes-preparedness-against\" target=\"_blank\" rel=\"noreferrer noopener\">En savoir plus<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le Centre europ\u00e9en de pr\u00e9vention et de contr\u00f4le des maladies (ECDC) recommande la cr\u00e9ation de quatre nouveaux laboratoires de r\u00e9f\u00e9rence de l&#8217;UE (EURL) pour la sant\u00e9 publique. Ces laboratoires sp\u00e9cialis\u00e9s fourniraient un soutien scientifique expert, renforceraient les capacit\u00e9s de diagnostic et contribueraient \u00e0 garantir des donn\u00e9es comparables et de haute qualit\u00e9 dans tous les pays [&hellip;]<\/p>\n","protected":false},"author":285,"featured_media":31263,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,37,26],"tags":[6697,6607,6733,6579,6698,6621],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l&#039;Europe face aux maladies infectieuses - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l&#039;Europe face aux maladies infectieuses - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-05T09:56:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T09:56:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png\" \/>\n\t<meta property=\"og:image:width\" content=\"789\" \/>\n\t<meta property=\"og:image:height\" content=\"237\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Aurore Brunet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Aurore Brunet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\"},\"author\":{\"name\":\"Aurore Brunet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41\"},\"headline\":\"L&#8217;ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l&#8217;Europe face aux maladies infectieuses\",\"datePublished\":\"2026-03-05T09:56:26+00:00\",\"dateModified\":\"2026-03-05T09:56:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\"},\"wordCount\":195,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png\",\"keywords\":[\"AMR\",\"Antibior\u00e9sistance\",\"Antibiotic Resistance\",\"antimicrobial\",\"Antimicrobial Resistance\",\"OneHealth\"],\"articleSection\":[\"Actualit\u00e9s\",\"Bilans, rapports et recommandations\",\"Infos pratiques &amp; communications\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\",\"name\":\"L'ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l'Europe face aux maladies infectieuses - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png\",\"datePublished\":\"2026-03-05T09:56:26+00:00\",\"dateModified\":\"2026-03-05T09:56:28+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png\",\"width\":789,\"height\":237},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"L\u2019ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l\u2019Europe face aux maladies infectieuses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41\",\"name\":\"Aurore Brunet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l'Europe face aux maladies infectieuses - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/","og_locale":"fr_FR","og_type":"article","og_title":"L'ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l'Europe face aux maladies infectieuses - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2026-03-05T09:56:26+00:00","article_modified_time":"2026-03-05T09:56:28+00:00","og_image":[{"width":789,"height":237,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png","type":"image\/png"}],"author":"Aurore Brunet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Aurore Brunet","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/"},"author":{"name":"Aurore Brunet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41"},"headline":"L&#8217;ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l&#8217;Europe face aux maladies infectieuses","datePublished":"2026-03-05T09:56:26+00:00","dateModified":"2026-03-05T09:56:28+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/"},"wordCount":195,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png","keywords":["AMR","Antibior\u00e9sistance","Antibiotic Resistance","antimicrobial","Antimicrobial Resistance","OneHealth"],"articleSection":["Actualit\u00e9s","Bilans, rapports et recommandations","Infos pratiques &amp; communications"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/","name":"L'ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l'Europe face aux maladies infectieuses - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png","datePublished":"2026-03-05T09:56:26+00:00","dateModified":"2026-03-05T09:56:28+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/03\/Banniere-ECDC.png","width":789,"height":237},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lecdc-propose-la-creation-de-nouveaux-laboratoires-de-reference-europeens-afin-de-renforcer-la-preparation-de-leurope-face-aux-maladies-infectieuses\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"L\u2019ECDC propose la cr\u00e9ation de nouveaux laboratoires de r\u00e9f\u00e9rence europ\u00e9ens afin de renforcer la pr\u00e9paration de l\u2019Europe face aux maladies infectieuses"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41","name":"Aurore Brunet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-22 04:40:09","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31262"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/285"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=31262"}],"version-history":[{"count":1,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31262\/revisions"}],"predecessor-version":[{"id":31265,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31262\/revisions\/31265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/31263"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=31262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=31262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=31262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}